Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JAK3i 是JAK3激酶的选择性共价抑制剂。JAK3i 揭示了STAT5磷酸化的两个不同的时间波,并且更有效地靶向第二波,这是细胞周期进程和T 细胞增殖所必需的。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 2,350 | 现货 | ||
5 mg | ¥ 5,630 | 现货 | ||
10 mg | ¥ 7,790 | 现货 | ||
25 mg | ¥ 11,200 | 现货 | ||
50 mg | ¥ 13,800 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 4,780 | 现货 |
产品描述 | JAK3i is a selective covalent inhibitor of JAK3 kinase. JAK3i reveals two distinct temporal waves of STAT5 phosphorylation and more potently targets the second wave, which is required for cell cycle progression and T cell proliferation. |
体外活性 | We targeted the key downstream IL2R-intermediate JAK 3 using a clinically relevant highly specific JAK3-inhibitor (JAK3i; PF-06651600) that potently inhibited STAT5-phosphorylation in vitro. Low-dose JAK3i combined with cellular and peptide vaccine strategies further decreased tumor load compared with both monotherapies alone.[1] The subsequent phenotype ontology results have revealed JAK3I, PLCG2, and ZEB2 as key hub genes contributing to the inflammation underlying cardiovascular and immune response related phenotypes.[2] |
别名 | JAK-3i, JAK 3i |
分子量 | 354.34 |
分子式 | C18H15FN4O3 |
CAS No. | 1918238-72-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (28.22 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.8221 mL | 14.1107 mL | 28.2215 mL | 70.5537 mL |
5 mM | 0.5644 mL | 2.8221 mL | 5.6443 mL | 14.1107 mL | |
10 mM | 0.2822 mL | 1.4111 mL | 2.8221 mL | 7.0554 mL | |
20 mM | 0.1411 mL | 0.7055 mL | 1.4111 mL | 3.5277 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
JAK3i 1918238-72-8 Angiogenesis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK JAK-3i JAK 3i Inhibitor inhibitor inhibit